InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Tyagarajan Seshu. Officer active across 1 company, notably Candel Therapeutics, Inc.. In total, 14 reports have been logged. Split: 1 buy · 8 sells. Total volume traded: €796k. History available since 28 November 2022. The latest transaction was filed on 17 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Tyagarajan Seshu is a declarant linked to Candel Therapeutics, Inc. (XNAS), where he is Chief Technology Officer. He has 13 filings in total, and across the 13 recent filings held in the sample, the transactions show EUR 4,822 of purchases and EUR 718,579 of sales between 2022-11-30 and 2026-07-01, with Cession as the modal transaction nature.